Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Interest Expenses (2016 - 2019)

Historic Interest Expenses for Harvard Bioscience (HBIO) over the last 10 years, with Q3 2019 value amounting to $1.3 million.

  • Harvard Bioscience's Interest Expenses fell 754.46% to $1.3 million in Q3 2019 from the same period last year, while for Jun 2020 it was $1.3 million, marking a year-over-year decrease of 7664.18%. This contributed to the annual value of $5.4 million for FY2018, which is 65273.49% up from last year.
  • According to the latest figures from Q3 2019, Harvard Bioscience's Interest Expenses is $1.3 million, which was down 754.46% from $1.4 million recorded in Q2 2019.
  • Over the past 5 years, Harvard Bioscience's Interest Expenses peaked at $1.5 million during Q4 2018, and registered a low of $141000.0 during Q3 2016.
  • Moreover, its 5-year median value for Interest Expenses was $205000.0 (2015), whereas its average is $615526.3.
  • In the last 5 years, Harvard Bioscience's Interest Expenses crashed by 3088.24% in 2016 and then soared by 74640.88% in 2018.
  • Harvard Bioscience's Interest Expenses (Quarter) stood at $205000.0 in 2015, then decreased by 24.39% to $155000.0 in 2016, then grew by 16.77% to $181000.0 in 2017, then surged by 746.41% to $1.5 million in 2018, then decreased by 12.01% to $1.3 million in 2019.
  • Its Interest Expenses was $1.3 million in Q3 2019, compared to $1.4 million in Q2 2019 and $1.4 million in Q1 2019.